Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB ) is 20.40%. Trinity Biotech's revenue for the same period is $82.97 million. The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO ) is